Follow
Maoyu Peng
Maoyu Peng
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor
Y Zheng, M Peng, Z Wang, JM Asara, AL Tyner
Molecular and cellular biology 30 (17), 4280-4292, 2010
822010
Cloning and Characterization of a Rice Field Eel vasa-Like Gene cDNA and Its Expression in Gonads During Natural Sex Transformation
D Ye, D Lv, P Song, M Peng, Y Chen, M Guo, Q Yang, Y Hu
Biochemical genetics 45, 211-224, 2007
462007
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors
M Peng, R Emmadi, Z Wang, EL Wiley, PH Gann, SA Khan, N Banerji, ...
Oncotarget 5 (15), 6038, 2014
402014
Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse
M Peng, SM Ball-Kell, AL Tyner
Cell death & disease 6 (8), e1848-e1848, 2015
222015
Current strategies employed in the manipulation of gene expression for clinical purposes
HC Tsai, V Pietrobon, M Peng, S Wang, L Zhao, FM Marincola, Q Cai
Journal of Translational Medicine 20 (1), 535, 2022
172022
Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models
M Peng, SM Ball-Kell, RR Franks, H Xie, AL Tyner
Oncogenesis 2 (12), e81-e81, 2013
172013
Molecular cloning and sequence analysis of full-length growth hormone cDNAs from six important economic fishes
JN Zhang, P Song, JR Hu, SJ Mo, MY Peng, W Zhou, JX Zou, YC Hu
ActaGeneticaSinica 32 (1), 19-29, 2005
122005
Polymorphism in intron 2 of crucian carp GH I gene
SJ Mo, P Song, DJ Luo, MY Peng, L Zhang, HL Yao, W Zhou, JN Zhang, ...
Yi Chuan Xue Bao= Acta Genetica Sinica 31 (6), 582-590, 2004
72004
Inhibition of PI3K Alpha and PI3K delta with copanlisib shows preclinical activity as a single agent and in combination in multiple myeloma
SM Larson, MY Peng, M Mead, A Vandross, D Conklin, E Von Euw, ...
Blood 130, 3084, 2017
32017
Fatty acid synthase (FASN) inhibitors synergize with carfilzomib (CFZ) in acute myeloid leukemia (AML) and multiple myeloma (MM)
M Peng, SN Ghafouri, MSJ McDermott, DJ Slamon, SM Larson
Cancer Research 82 (12_Supplement), 3023-3023, 2022
12022
Activity of carfilzomib (CFZ) in acute myeloid leukemia (AML) as a single agent and in novel combinations
MY Peng, Y Abaza, M Mcdermott, M Mead, DJ Slamon, S Larson
Blood 136, 6-7, 2020
12020
Phospho-S6 levels correlate with response to Copanlisib (BAY 80-6946) in multiple myeloma
S Larson, MY Peng, M Mead, A Vandross, D Conklin, EV Euw, DJ Slamon
Cancer Research 77 (13_Supplement), 136-136, 2017
12017
Activity of carfilzomib (CFZ) alone and in combination with cytarabine and chloroquine diphosphate (CHQ) in acute myeloid leukemia (AML)
MY Peng, Y Abaza, D Conklin, EV Euw, M Mead, J Timmerman, ...
Cancer Research 79 (13_Supplement), 297-297, 2019
2019
Copanlisib Has Activity As a Single Agent and in Combination with Carfilzomib and Response Correlates with Phospho-S6 Level
S Larson, MY Peng, A Vandross, M Mead, E Von Euw, D Conklin, ...
Clinical Lymphoma, Myeloma and Leukemia 17 (1), e132, 2017
2017
Activity of the Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Copanlisib, As a Single Agent and in Combination with Carfilzomib in Multiple Myeloma
SM Larson, MY Peng, A Vandross, M Mead, Z Fuchs, D Conklin, ...
Blood, The Journal of the American Society of Hematology 128 (22), 5665-5665, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–15